Impact of oral contraceptives and metformin on advanced lipid phenotyping in polycystic ovary syndrome

Iris T Lee, Daniel E Soffer, Alan T Remaley, Martin P Playford, Nehal N Mehta, Christos Coutifaris, Richard S Legro, Anuja Dokras

Open source

DOI
10.1093/ejendo/lvag149
Published
2026-08
Container
European Journal of Endocrinology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag149,
  title = {Impact of oral contraceptives and metformin on advanced lipid phenotyping in polycystic ovary syndrome},
  author = {Iris T Lee and Daniel E Soffer and Alan T Remaley and Martin P Playford and Nehal N Mehta and Christos Coutifaris and Richard S Legro and Anuja Dokras},
  year = {2026},
  journal = {European Journal of Endocrinology},
  doi = {10.1093/ejendo/lvag149},
  url = {https://doi.org/10.1093/ejendo/lvag149}
}

RIS

TY  - JOUR
TI  - Impact of oral contraceptives and metformin on advanced lipid phenotyping in polycystic ovary syndrome
AU  - Iris T Lee
AU  - Daniel E Soffer
AU  - Alan T Remaley
AU  - Martin P Playford
AU  - Nehal N Mehta
AU  - Christos Coutifaris
AU  - Richard S Legro
AU  - Anuja Dokras
PY  - 2026
JO  - European Journal of Endocrinology
DO  - 10.1093/ejendo/lvag149
UR  - https://doi.org/10.1093/ejendo/lvag149
ER  - 

APA

Lee, I. T., Soffer, D. E., Remaley, A. T., Playford, M. P., Mehta, N. N., Coutifaris, C., Legro, R. S., & Dokras, A. (2026). Impact of oral contraceptives and metformin on advanced lipid phenotyping in polycystic ovary syndrome. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag149

Source records